Navigation Links
University of College London Hospitals (UCLH) Selects GEO SCAN Medical as New Standard of Care for the Detection and Treatment of Prostate Cancer

Sarasota, FL (PRWEB) December 04, 2012

University of College London Hospitals (UCLH) has selected GEO SCAN Medical as its new standard of care for the diagnosis, management and treatment of prostate cancer. The BioJet™ solution, a unique, cost-effective 3D MR Fusion technology, will dramatically change the way prostate cancer is treated and managed. The goal is to strengthen care delivery by reliably fusing MR images with real-time ultrasound, which greatly increases visibility of the “regions of interest” for prostate biopsy.

BioJet is a minimally invasive software/hardware platform which received final approval 510(k) clearance from the Food and Drug Administration (FDA) in August 2012, and the European CE Mark Approval in January.

“After completing three successful cases,” said Dr. Mark Emberton, M.D., UCL, "we found that the BioJet software enables more precise results. We will continue to test the limits of fusion technology as our new standard of prostate care." In 2012, the academic hospital enlisted GEO SCAN to provide better information for staging of prostate cancer, in order to determine the best clinical path and course treatment for optimal outcomes.

In addition to the success at UCLH, GEO SCAN has also recently launched its first MR Fusion cases in the United States. Michael S. McGuire, M.D., has been using the system as of October at NorthShore University HealthSystem. McGuire, Co-Director of the John and Carol Walter Center for Urological Health, said: "We've been seeking a solution to the challenge of how to reliably fuse two modalities for more precise biopsy - and this now provides that capability."

GEO SCAN's worldwide sales and distribution activities have already resulted in multiple success cases. GEO SCAN's goal is to expand the BioJet technology with its distribution partners into these territories: EMEA (Europe, Middle East and Africa), Asia and Pacific Rim; as well as the Americas (North and South).

"As the industry moves toward new care models, we're pleased to pave the way for innovative approaches in the detection, treatment and management of prostate cancer," said Manfred Sablowski, chief executive officer of GEO SCAN Medical. "With enhanced visibility, caregivers can now clearly define regions of interest for biopsy - which will ultimately allow better staging and improved clinical outcomes."

GEO SCAN Medical is a global medical device company that develops, manufactures and markets innovative products in the field of minimally invasive Ultrasound and MR image guided medical procedures. For more information, please visit

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. iLab Solutions Core Facility Management Software Named a University Business Magazine 2012 Readers’ Choice Top Product
2. Ben-Gurion University awarded $6.5 million grant to develop nano thin infrared night vision glasses
3. IntelliCell BioSciences Announces Research Agreement with the New Jersey Center for Biomaterials at Rutgers-The State University of New Jersey
4. Moscow State University Hospital Selects Ekahau RTLS to Improve Operations and Patient Safety
5. Ben-Gurion University develops side-illuminated ultra-efficient solar cell designs
6. New strategy for fingerprint visualization developed at Hebrew University
7. Oxford University Hospitals NHS Trust and the Bodleian Libraries Select ClinicalKey
8. Tel Aviv University to spearhead groundbreaking nanotechnology consortium
9. University of Kentucky Medical Center Transplants States 1st SynCardia Total Artificial Heart Patient
10. Islet Sciences Announces Exclusive License Agreement with the University of California (UCLA) to Commercialize Small Molecules for Islet Expansion
11. University of California, San Francisco (UCSF) Selects Conflict of Interest Management System
Post Your Comments:
(Date:11/25/2015)... 2015 --> ... - 2020 report analyzes that automating biobanking workflow ... in long-term samples, minimizing manual errors, improving the ... manual errors such as mislabeling or inaccurate sample ... plays a vital role in blood fractionation, DNA ...
(Date:11/25/2015)... -- PharmAthene, Inc. (NYSE MKT: PIP) announced  today that its ... (Rights Plan) in an effort to preserve the value ... 382 of the Internal Revenue Code (Code). ... its NOLs could be substantially limited if the Company ... of the Code. In general, an ownership change occurs ...
(Date:11/25/2015)... 2 nouvelles études permettent d , ... les souches bactériennes retrouvées dans la plaque dentaire ... . Ces recherches  ouvrent une nouvelle voie ... de l,un des problèmes de santé les plus ... --> 2 nouvelles études permettent d , ...
(Date:11/25/2015)... BRUSSELS , November 25, 2015 ... in cat and human plaque and pave the way for ... health problems in cats     ... the most commonly diagnosed health problems in cats, yet relatively ... until now. Two collaborative studies have been conducted by researchers ...
Breaking Biology Technology:
(Date:11/20/2015)... -- NXTD ) ("NXT-ID" or the "Company"), ... commerce market and creator of the Wocket® smart wallet, ... interviewed on The RedChip Money Report television ... Bloomberg Europe , Bloomberg Asia, Bloomberg Australia, and ... ) ("NXT-ID" or the "Company"), a biometric authentication company ...
(Date:11/19/2015)... MOUNTAIN VIEW, Calif. , Nov. 19, 2015 /PRNewswire/ ... authentication market, Frost & Sullivan recognizes BIO-key with the ... Strategy Leadership. Each year, Frost & Sullivan presents this ... comprehensive product line catering to the needs of the ... which the product line meets and expands on customer ...
(Date:11/19/2015)... , Nov. 19, 2015  Although some 350 ... is dominated by a few companies, according to Kalorama ... own 51% of the market share of the 6.1 ... The World Market for Molecular Diagnostic s . ... "The market is still controlled by one company and ...
Breaking Biology News(10 mins):